<?xml version="1.0" encoding="UTF-8"?>
<p>In the previous DD study, 60% of patients developed an infusion reaction, characterized by immediate events such as back pain, chest pain/tightness, hypotension, pruritus, vasodilation, and dyspnea, within 24 h of study drug infusion.
 <xref rid="cas13513-bib-0015" ref-type="ref">15</xref> However, the frequency of infusion reaction in the present study was low, likely due to the required use of dexamethasone (4‐8 mg, i.v.) as premedication, which was based on several previous reports of DD optimal use.
 <xref rid="cas13513-bib-0021" ref-type="ref">21</xref>, 
 <xref rid="cas13513-bib-0022" ref-type="ref">22</xref> Furthermore, the lower levels of impurities such as misfolded and/or aggregated proteins might also have contributed to this discrepancy. Another report described a reduced frequency of AEs in subsequent cycles of DD treatment,
 <xref rid="cas13513-bib-0016" ref-type="ref">16</xref> and a similar tendency was observed in the present study. However, we should carefully consider the influence of confounding from early discontinued patients and evaluate the similarities of these AE profiles in further studies.
</p>
